Showing 1 - 8 of 8 trials – Showing only trials currently accepting patients

• Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors

  Stanford is currently accepting patients for this trial.

• CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

  Stanford is currently accepting patients for this trial.

• Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

  Stanford is currently accepting patients for this trial.

• A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  Stanford is currently accepting patients for this trial.

• Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

  Stanford is currently accepting patients for this trial.

• Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

  Stanford is currently accepting patients for this trial.

• Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

  Stanford is currently accepting patients for this trial.

• Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

  Stanford is currently accepting patients for this trial.